Summary

Patients with uncontrolled type 2 diabetes display greater reductions in HbA1c using a regimen of a once-weekly autoinjection of exenatide as compared with twice-daily injections of exenatide. The results of the randomized, double-blind Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes study [DURATION-NEO-1; NCT01652716] are presented in this article.